These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7481855)
1. Phase I study of paclitaxel and carboplatin: implications for trials in head and neck cancer. Creaven P; Raghavan D; Pendyala L; Perez R; Loewen G; Meropol N; Levine E; Hicks W Semin Oncol; 1995 Oct; 22(5 Suppl 12):13-6. PubMed ID: 7481855 [TBL] [Abstract][Full Text] [Related]
2. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network. Langer CJ; Millenson M; Rosvold E; Litwin S; McAleer CA; Bonjo CA; Ozols R Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128 [TBL] [Abstract][Full Text] [Related]
3. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network. Langer CJ; Millenson M; O'Dwyer P; Kosierowski R; Alexander R; Litwin S; McAleer CA; Bonjo CA; Ozols R Semin Oncol; 1996 Dec; 23(6 Suppl 16):35-41. PubMed ID: 9007119 [TBL] [Abstract][Full Text] [Related]
4. Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study. Fountzilas G; Athanassiadis A; Samantas E; Skarlos D; Kalogera-Fountzila A; Nikolaou A; Bacoyiannis H; Stathopoulos G; Kosmidis P; Daniilidis J Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-65-S2-67. PubMed ID: 9045340 [TBL] [Abstract][Full Text] [Related]
5. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001. Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129 [TBL] [Abstract][Full Text] [Related]
6. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma. Edelman MJ; Meyers FJ; Houston J; Lauder I Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience. Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Johnson S; Ozols RF Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025 [TBL] [Abstract][Full Text] [Related]
8. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results. Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971 [TBL] [Abstract][Full Text] [Related]
9. A clinical and pharmacokinetic study of high-dose carboplatin, paclitaxel, granulocyte colony-stimulating factor, and peripheral blood stem cells in patients with unresectable or metastatic cancer. Shea T; Graham M; Bernard S; Steagall A; Wiley J; Serody J; Brecher M; Bentley S; Johnston C; Vaisman A Semin Oncol; 1995 Oct; 22(5 Suppl 12):80-5. PubMed ID: 7481867 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel and carboplatin in early phase studies: Roswell Park Cancer Institute experience in the subset of patients with lung cancer. Creaven PJ; Raghavan D; Pendyala L; Loewen G; Kindler HL; Berghorn EJ Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-138-S12-143. PubMed ID: 9331139 [TBL] [Abstract][Full Text] [Related]
11. Paclitaxel and carboplatin in head and neck cancer. Dunphy F; Boyd J; Dunleavy T Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-25-S19-27. PubMed ID: 9427261 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer. Langer CJ; Leighton J; McAleer C; Comis R; O'Dwyer P; Ozols R Semin Oncol; 1995 Jun; 22(3 Suppl 6):64-9. PubMed ID: 7541156 [TBL] [Abstract][Full Text] [Related]
13. Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer. Giaccone G; Huizing M; Postmus PE; ten Bokkel Huinink WW; Koolen M; van Zandwijk N; Vermorken JB; Beijnen JH; Dalesio O; Pinedo HM Semin Oncol; 1995 Aug; 22(4 Suppl 9):78-82. PubMed ID: 7544030 [TBL] [Abstract][Full Text] [Related]
14. Preliminary results of two dose-finding studies of paclitaxel (Taxol) and carboplatin in non-small cell lung and ovarian cancers: a European Cancer Centre effort. Giaccone G; Huizing M; ten Bokkel Huinink W; Koolen M; Postmus P; van Kralingen K; van Zandwijk N; Vermorken J; Beijnen J; Dalesio O Semin Oncol; 1994 Oct; 21(5 Suppl 8):34-8. PubMed ID: 7939761 [TBL] [Abstract][Full Text] [Related]
15. Feasibility and pharmacokinetics of paclitaxel, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non-small cell lung cancer. Aisner J; Belani CP; Kearns C; Conley B; Hiponia D; Engstrom C; Zuhowski E; Egorin MJ Semin Oncol; 1995 Oct; 22(5 Suppl 12):17-21. PubMed ID: 7481856 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancer. Belani CP; Aisner J; Hiponia D; Engstrom C Semin Oncol; 1995 Aug; 22(4 Suppl 9):7-12. PubMed ID: 7544028 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study. Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219 [TBL] [Abstract][Full Text] [Related]
18. A phase I/II trial of combination paclitaxel and carboplatin in advanced or metastatic non-small cell lung cancer: preliminary results of an ongoing study. Natale RB Semin Oncol; 1995 Dec; 22(6 Suppl 15):34-7. PubMed ID: 8643968 [TBL] [Abstract][Full Text] [Related]
19. Phase I study of paclitaxel as a 3-hour infusion followed by carboplatin in untreated patients with stage IV non-small cell lung cancer. Rowinsky EK; Flood WA; Sartorius SE; Bowling MK; Wagner J; Ettinger DS Semin Oncol; 1995 Aug; 22(4 Suppl 9):48-54. PubMed ID: 7644928 [TBL] [Abstract][Full Text] [Related]